Castleview Partners, LLC Bristol Myers Squibb CO Transaction History

Castleview Partners, LLC

$112 Million
Q2 2025

A detailed history of Castleview Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Castleview Partners, LLC holds 69,470 shares of BMY stock, worth $3.19 Million. This represents 2.88% of its overall portfolio holdings.

Number of Shares

69,470

Previous 67,896 2.32%

Holding current value

$3.19 Million

Previous $4.14 Million 22.34%

% of portfolio

2.88%

Previous 3.74%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	BUY	$44.12 - $59.6 $69,444 - $93,810	1,574 Added 2.32%	69,470 $3.22 Million
Q1 2025 Apr 21, 2025	BUY	$53.9 - $63.11 $684,691 - $801,686	12,703 Added 23.02%	67,896 $4.14 Million
Q4 2024 Jan 21, 2025	BUY	$51.92 - $59.94 $298,643 - $344,774	5,752 Added 11.63%	55,193 $3.12 Million
Q3 2024 Oct 21, 2024	BUY	$39.66 - $51.75 $1.73 Million - $2.26 Million	43,730 Added 765.72%	49,441 $2.56 Million
Q2 2024 Jul 31, 2024	BUY	$40.25 - $52.99 $81,707 - $107,569	2,030 Added 55.15%	5,711 $237,000
Q1 2024 May 09, 2024	BUY	$47.98 - $54.4 $57,528 - $65,225	1,199 Added 48.31%	3,681 $199,000
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $20,458 - $24,412	422 Added 20.49%	2,482 $127,000
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $3,473 - $3,883	-60 Reduced 2.83%	2,060 $119,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $88,875 - $98,682	-1,395 Reduced 39.69%	2,120 $135,000
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $8,542 - $9,688	130 Added 3.84%	3,515 $243,000
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $36,362 - $43,058	531 Added 18.61%	3,385 $243,000
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $370 - $218,994	2,850 Added 71250.0%	2,854 $203,000
Q2 2022 Aug 17, 2022	SELL	$72.62 - $79.98 $16.4 Million - $18.1 Million	-226,222 Reduced 100.0%	4 $0
Q2 2022 Aug 16, 2022	BUY	$72.62 - $79.98 $16.2 Million - $17.8 Million	222,949 Added 6803.45%	226,226 $17.4 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $15.4 Million - $18.5 Million	-250,861 Reduced 98.71%	3,277 $239,000
Q4 2021 Feb 17, 2022	BUY	$53.63 - $62.52 $13.5 Million - $15.7 Million	251,472 Added 9432.56%	254,138 $15.8 Million
Q2 2021 Aug 17, 2021	SELL	$61.91 - $67.42 $190,620 - $207,586	-3,079 Reduced 53.59%	2,666 $178,000
Q1 2018 May 07, 2018	BUY	$59.92 - $68.98 $344,240 - $396,290	5,745 New	5,745 $363,000

Others Institutions Holding BMY

# of Institutions

2,730

Shares Held

1.59B

Call Options Held

26M

Put Options Held

24.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $97.8B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.

Account

Castleview Partners, LLC Bristol Myers Squibb CO Transaction History